Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-glutamine gamma-glutamyltransferase 4 (TGM4) is an enzyme primarily expressed in the prostate, where it catalyzes the cross-linking of proteins and the conjugation of polyamines to specific proteins, processes associated with seminal plug formation and the mammalian reproductive process. TGM4 is being investigated as a biological factor and potential biomarker for the diagnosis and prognosis of prostate cancer. Its molecular function falls under protein-glutamine gamma-glutamyltransferase activity, and its gene (TGM4) is located on human chromosome 3[1][3][5][6].
Enzyme inhibition (inferred, since it is an enzyme; specific inhibitors not reported in provided sources)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-glutamine gamma-glutamyltransferase 4 (TGM4).